Priority One

Beta Glucan (1,3/1,6)

F
N+ Score45
Vitamins & MineralsServing: 1 Vegetarian Capsule(s)Type: Fiber and Other Nutrients

Priority One Beta Glucan (1,3/1,6) is a single-ingredient supplement providing 500mg of Beta-(1,3/1,6)-D-Glucan per vegetarian capsule. Beta-glucans are a type of soluble fiber commonly researched for their potential role in supporting immune function. This product received an N+ Score of 45, which corresponds to an 'F' grade, indicating a below-average rating based on Nutrienting.com's evaluation criteria. While the label transparency is 100%, the formula's completeness is 0% as it's a single ingredient product, and the ingredient adequacy is 50%, suggesting the dosage may not align with all research-backed recommendations for its intended use. This product might be considered by individuals seeking a standalone beta-glucan supplement with a transparent label, though its N+ Score suggests potential limitations in overall formulation value.

About This Product

Beta Glucan (1,3/1,6) by Priority One is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 45/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Missing several expected ingredients for its category
  • Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Beta-(1,3/1,6)-D-Glucan500.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.